Luigi Bartalena
#140,430
Most Influential Person Now
Researcher
Luigi Bartalena's AcademicInfluence.com Rankings
Luigi Bartalenacomputer-science Degrees
Computer Science
#6710
World Rank
#7070
Historical Rank
Machine Learning
#2270
World Rank
#2298
Historical Rank
Artificial Intelligence
#2535
World Rank
#2576
Historical Rank
Database
#3794
World Rank
#3948
Historical Rank
Download Badge
Computer Science
Luigi Bartalena's Degrees
- PhD Computer Science University of Florence
- Masters Artificial Intelligence Consorzio ICoN
Similar Degrees You Can Earn
Why Is Luigi Bartalena Influential?
(Suggest an Edit or Addition)Luigi Bartalena's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy (2016) (687)
- Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO. (2008) (659)
- Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. (1998) (635)
- The effects of amiodarone on the thyroid. (2001) (508)
- 2018 European Thyroid Association Guideline for the Management of Graves’ Hyperthyroidism (2018) (456)
- Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy. (2008) (388)
- Epidemiology and prevention of Graves' ophthalmopathy. (2002) (386)
- Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism. (1989) (303)
- Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathy. (2012) (268)
- Cigarette Smoking and Treatment Outcomes in Graves Ophthalmopathy (1998) (251)
- Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone. (1983) (250)
- Selenium and the course of mild Graves' orbitopathy. (2011) (248)
- Clinical practice. Graves' ophthalmopathy. (2009) (235)
- Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed graves' hyperthyroidism seen at a single center. (2013) (227)
- Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study. (1996) (226)
- Complex alteration of thyroid function in healthy centenarians. (1993) (224)
- The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) (201)
- Thyroid function differently affects serum cystatin Cand creatinine concentrations (2005) (192)
- Diagnosis and management of Graves disease: a global overview (2013) (190)
- Extrathyroidal manifestations of Graves’ disease: a 2014 update (2014) (185)
- More on smoking habits and Graves’ ophthalmopathy (1989) (179)
- Surgical treatment of Graves' disease: subtotal or total thyroidectomy? (1996) (168)
- Serum interleukin-6 in amiodarone-induced thyrotoxicosis. (1994) (167)
- Approach to the patient with amiodarone-induced thyrotoxicosis. (2010) (167)
- THE 2021 EUROPEAN GROUP ON GRAVES' ORBITOPATHY (EUGOGO) CLINICAL PRACTICE GUIDELINES FOR THE MEDICAL MANAGEMENT OF GRAVES' ORBITOPATHY. (2021) (163)
- Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis. (1997) (159)
- Cigarette smoking and the thyroid. (1995) (158)
- A 2013 European survey of clinical practice patterns in the management of Graves' disease (2016) (155)
- Thyroid hormone transport proteins. (1993) (146)
- Acute and severe liver damage associated with intravenous glucocorticoid pulse therapy in patients with Graves' ophthalmopathy. (2004) (145)
- The various effects of amiodarone on thyroid function. (2001) (144)
- 2018 European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid Dysfunction (2018) (138)
- Recent achievements in studies on thyroid hormone-binding proteins. (1990) (133)
- Effects of total thyroid ablation versus near-total thyroidectomy alone on mild to moderate Graves' orbitopathy treated with intravenous glucocorticoids. (2007) (124)
- Thyroid vascularity and blood flow are not dependent on serum thyroid hormone levels: studies in vivo by color flow doppler sonography. (1999) (119)
- AMIODARONE IODINE‐INDUCED HYPOTHYROIDISM: RISK FACTORS AND FOLLOW‐UP IN 28 CASES (1987) (117)
- Amiodarone and the thyroid: A 2012 update (2012) (117)
- Lower dose prednisone prevents radioiodine-associated exacerbation of initially mild or absent graves' orbitopathy: a retrospective cohort study. (2010) (116)
- Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial. (2018) (110)
- Long-term safety of orbital radiotherapy for Graves' ophthalmopathy. (2003) (109)
- ORBITAL COBALT IRRADIATION COMBINED WITH RETROBULBAR OR SYSTEMIC CORTICOSTEROIDS FOR GRAVES' OPHTHALMOPATHY: A COMPARATIVE STUDY (1987) (108)
- Prevalence and natural history of Graves’ orbitopathy in the XXI century (2013) (108)
- Amiodarone: a common source of iodine-induced thyrotoxicosis. (1987) (104)
- Comparison of radioiodine with radioiodine plus lithium in the treatment of Graves' hyperthyroidism. (1999) (102)
- Fatal and non-fatal adverse events of glucocorticoid therapy for Graves' orbitopathy: a questionnaire survey among members of the European Thyroid Association. (2012) (96)
- The dilemma of how to manage Graves' hyperthyroidism in patients with associated orbitopathy. (2011) (94)
- Relationship of the increased serum interleukin-6 concentration to changes of thyroid function in nonthyroidal illness (1994) (92)
- Role of cytokines in the pathogenesis of the euthyroid sick syndrome. (1998) (92)
- Adverse Effects of Thyroid Hormone Preparations and Antithyroid Drugs (1996) (91)
- Vitreous Substitutes: The Present and the Future (2014) (85)
- Graves' ophthalmopathy: a preventable disease? (2002) (85)
- Diagnosis and management of amiodarone‐induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association (2004) (85)
- Variations in thyroid hormone transport proteins and their clinical implications. (1992) (84)
- Efficacy and safety of orbital radiotherapy for graves' orbitopathy. (2012) (83)
- Interleukin-6: a marker of thyroid-destructive processes? (1994) (82)
- Nocturnal serum thyrotropin (TSH) surge and the TSH response to TSH-releasing hormone: dissociated behavior in untreated depressives. (1990) (79)
- Treatment of type II amiodarone-induced thyrotoxicosis by either iopanoic acid or glucocorticoids: a prospective, randomized study. (2003) (77)
- Prevalence and functional significance of antipituitary antibodies in patients with autoimmune and non-autoimmune thyroid diseases. (2007) (77)
- Graves’ ophthalmopathy: State of the art and perspectives (2004) (77)
- Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal. (2010) (77)
- High prevalence of subacute thyroiditis during summer season in Italy (1987) (77)
- Enhanced susceptibility to amiodarone-induced hypothyroidism in patients with thyroid autoimmune disease. (1994) (76)
- Diagnosis and management of amiodarone‐induced thyrotoxicosis: similarities and differences between North American and European thyroidologists * (2008) (75)
- Therapeutic controversies. Retro-orbital radiation and radioactive iodide ablation of the thyroid may be good for Graves' ophthalmopathy. (1995) (73)
- Epidemiology, Natural History, Risk Factors, and Prevention of Graves’ Orbitopathy (2020) (73)
- The American Thyroid Association/American Association of Clinical Endocrinologists guidelines for hyperthyroidism and other causes of thyrotoxicosis: a European perspective. (2011) (73)
- Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves' disease. (2002) (71)
- PREGO (presentation of Graves’ orbitopathy) study: changes in referral patterns to European Group On Graves’ Orbitopathy (EUGOGO) centres over the period from 2000 to 2012 (2015) (71)
- Prevention of Graves' ophthalmopathy. (2012) (71)
- COMPARISON BETWEEN THYROID STIMULATING AND TSH‐BINDING INHIBITING IMMUNOGLOBULINS OF GRAVES' DISEASE (1981) (69)
- Orbital radiotherapy for Graves' ophthalmopathy. (2002) (68)
- Thyroid color flow doppler sonography and radioiodine uptake in 55 consecutive patients with amiodarone-induced thyrotoxicosis (2003) (68)
- RECIPROCAL CHANGES OF SERUM THYROGLOBULIN AND TSH IN RESIDENTS OF A MODERATE ENDEMIC GOITRE AREA (1985) (67)
- Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations. (2007) (67)
- Interleukin-6 inhibits corticosteroid-binding globulin synthesis by human hepatoblastoma-derived (Hep G2) cells. (1993) (66)
- Orbital Decompression in Graves' Ophthalmopathy by Medial and Lateral Wall Removal (2005) (64)
- Oxidative stress and Graves' ophthalmopathy: In vitro studies and therapeutic implications (2003) (64)
- Increased serum interleukin-6 concentration in patients with subacute thyroiditis: relationship with concomitant changes in serum T4-binding globulin concentration (1993) (63)
- Effects of interleukin-6 on the expression of thyroid hormone-binding protein genes in cultured human hepatoblastoma-derived (Hep G2) cells. (1992) (62)
- Amiodarone‐induced thyrotoxicosis: a difficult diagnostic and therapeutic challenge * (2002) (62)
- Proportion of type 1 and type 2 amiodarone‐induced thyrotoxicosis has changed over a 27‐year period in Italy (2007) (61)
- Radioactive iodine thyroid uptake in patients with amiodarone-iodine-induced thyroid dysfunction. (1988) (60)
- Graves' disease occurring after subacute thyroiditis: report of a case and review of the literature. (1996) (60)
- Management of hyperthyroidism due to Graves’ disease: frequently asked questions and answers (if any) (2016) (60)
- Graves' Orbitopathy: Imperfect Treatments for a Rare Disease (2013) (58)
- Controversies in radioiodine therapy: relation to ophthalmopathy, the possible radioprotective effect of antithyroid drugs, and use in large goitres. (2002) (57)
- Identification of acromegalic patients at risk of developing colonic adenomas. (2006) (56)
- The nocturnal serum thyrotropin surge is abolished in patients with adrenocorticotropin (ACTH)-dependent or ACTH-independent Cushing's syndrome. (1991) (56)
- Preparation with iopanoic acid rapidly controls thyrotoxicosis in patients with amiodarone-induced thyrotoxicosis before thyroidectomy. (2002) (56)
- Factors affecting suppression of endogenous thyrotropin secretion by thyroxine treatment: retrospective analysis in athyreotic and goitrous patients. (1987) (56)
- HUMAN SERUM THYROTROPHIN MEASUREMENT BY ULTRASENSITIVE IMMUNORADIOMETRIC ASSAY AS A FIRST‐LINE TEST IN THE EVALUATION OF THYROID FUNCTION (1986) (55)
- Total thyroidectomy in patients with amiodarone-induced thyrotoxicosis and severe left ventricular systolic dysfunction. (2012) (54)
- Glucocorticoids are preferable to thionamides as first-line treatment for amiodarone-induced thyrotoxicosis due to destructive thyroiditis: a matched retrospective cohort study. (2009) (53)
- Does early response to intravenous glucocorticoids predict the final outcome in patients with moderate-to-severe and active Graves’ orbitopathy? (2017) (53)
- Thyroid autoimmunity and environment. (2009) (52)
- Lack of nocturnal serum thyrotropin surge after surgery. (1990) (49)
- Antithyroid drug treatment for Graves’ disease: baseline predictive models of relapse after treatment for a patient-tailored management (2018) (49)
- Effects of treatment modalities for Graves’ hyperthyroidism on Graves’ orbitopathy: a 2015 Italian Society of Endocrinology Consensus Statement (2015) (47)
- Effects of a mixture of polychlorinated biphenyls (Aroclor 1254) on the transcriptional activity of thyroid hormone receptor (2003) (47)
- PPARgamma inhibits GH synthesis and secretion and increases apoptosis of pituitary GH-secreting adenomas. (2004) (46)
- Relationship between management of hyperthyroidism and course of the ophthalmopathy (2004) (45)
- Continuation of amiodarone delays restoration of euthyroidism in patients with type 2 amiodarone-induced thyrotoxicosis treated with prednisone: a pilot study. (2011) (45)
- Measurement of serum free thyroid hormone concentrations: an essential tool for the diagnosis of thyroid dysfunction. (1996) (45)
- Evaluation of thyroid function in patients with rapid-cycling and non-rapid-cycling bipolar disorder (1990) (45)
- An update on medical management of Graves’ ophthalmopathy (2005) (44)
- Interleukin-6 and the thyroid. (1995) (42)
- Glucocorticoid therapy of Graves' ophthalmopathy. (2009) (42)
- The interplay between thyroid and liver: implications for clinical practice (2020) (41)
- The phenotype of newly diagnosed Graves’ disease in Italy in recent years is milder than in the past: results of a large observational longitudinal study (2016) (41)
- Evaluation of the nocturnal serum thyrotropin (TSH) surge, as assessed by TSH ultrasensitive assay, in patients receiving long term L-thyroxine suppression therapy and in patients with various thyroid disorders. (1987) (40)
- Predictive score for the development or progression of Graves' orbitopathy in patients with newly diagnosed Graves' hyperthyroidism. (2018) (40)
- Color flow doppler sonography in thyrotoxicosis factitia (1996) (40)
- Long-term outcome of thyroid function after amiodarone-induced thyrotoxicosis, as compared to subacute thyroiditis (2006) (40)
- Iopanoic acid rapidly controls Type I amiodarone-induced thyrotoxicosis prior to thyroidectomy (2002) (39)
- Peroxisome proliferator activated receptor gamma expression is reduced in the colonic mucosa of acromegalic patients. (2002) (39)
- Management of amiodarone‐induced thyrotoxicosis in Latin America: an electronic survey (2006) (38)
- Outcome Prediction of Treatment of Graves’ Hyperthyroidism with Antithyroid Drugs (2015) (36)
- Serum thyrotropin by ultrasensitive immunoradiometric assay and serum free thyroid hormones in pregnancy (1986) (35)
- The onset time of amiodarone-induced thyrotoxicosis (AIT) depends on AIT type. (2014) (35)
- Relationship between nocturnal serum thyrotropin peak and metabolic control in diabetic patients. (1993) (34)
- Octreotide treatment does not affect the size of most nonfunctioning pituitary adenomas (1993) (34)
- Simultaneous medullary and papillary thyroid cancer: two case reports (2007) (34)
- Therapy of Graves’ disease with sodium ipodate is associated with a high recurrence rate of hyperthyroidism (1991) (34)
- Effect of tunicamycin and monensin on secretion of thyroxine-binding globulin by cultured human hepatoma (Hep G2) cells. (1984) (34)
- Role of autoimmune and familial factors in goiter prevalence. Studies performed in a moderately endemic area (1986) (33)
- Study of serum 3,5,3'-triiodothyronine sulfate concentration in patients with systemic non-thyroidal illness. (1996) (33)
- Growth hormone inhibits apoptosis in human colonic cancer cell lines: antagonistic effects of peroxisome proliferator activated receptor-gamma ligands. (2004) (33)
- What to do for moderate‐to‐severe and active Graves’ orbitopathy if glucocorticoids fail? (2010) (33)
- Mutations in the SLC26A4 (pendrin) gene in patients with sensorineural deafness and enlarged vestibular aqueduct (2004) (32)
- Characterization of nascent and secreted thyroxine-binding globulin in cultured human hepatoma (Hep G2) cells. (1984) (32)
- Comparison between total thyroidectomy and medical therapy for amiodarone-induced thyrotoxicosis. (2019) (32)
- Editorial: glucocorticoids for Graves' ophthalmopathy: how and when. (2005) (31)
- Amiodarone-induced thyrotoxicosis: something new to refine the initial diagnosis? (2008) (31)
- Novel Immunomodulating Agents for Graves Orbitopathy (2008) (31)
- Effect of amiodarone on circulating antithyroid antibodies. (1988) (31)
- Radio-receptor assay of TSH: its use to detect thyroid-stimulating immunoglobulins (1978) (30)
- Recommendations for treatment of hypothyroidism with levothyroxine and levotriiodothyronine: a 2016 position statement of the Italian Society of Endocrinology and the Italian Thyroid Association (2016) (30)
- Polymorphism of human thyroxine-binding globulin. (1983) (29)
- Desethylamiodarone antagonizes the effect of thyroid hormone at the molecular level. (2001) (29)
- Orbital radiotherapy for Graves’ ophthalmopathy: Useful or useless? Safe or dangerous? (2003) (29)
- Lack of nocturnal serum thyrotropin (TSH) surge in patients with chronic renal failure undergoing regular maintenance hemofiltration: a case of central hypothyroidism. (1990) (28)
- Orbital radiotherapy for Graves' ophthalmopathy. (2004) (28)
- Management of thyroid eye disease (2002) (28)
- A novel mutation in the pendrin gene associated with Pendred's syndrome (2000) (27)
- Interleukin 6 effects on the pituitary-thyroid axis in the rat. (1994) (27)
- Thyroid hormone regulation of cell migration and oxidative metabolism in polymorphonuclear leukocytes: clinical evidence in thyroidectomized subjects on thyroxine replacement therapy. (2006) (26)
- l-thyroxine directly affects expression of thyroid hormone-sensitive genes: regulatory effect of RXRβ (1997) (26)
- Subclinical hypothyroidism and deep venous thrombosis (2007) (26)
- Immunomodulatory effect of vitamin D and its potential role in the prevention and treatment of thyroid autoimmunity: a narrative review (2019) (26)
- Studies on thyroid cell surface antigens using cultured human thyroid cells. (1982) (26)
- Pituitary apoplexy during pregnancy: a rare, but dangerous headache (2014) (25)
- Apoptosis is reduced in the colonic mucosa of patients with acromegaly (2005) (24)
- Thyroid-stimulating immunoglobulins. (1982) (23)
- Macular Hole Surgery: The Healing Process of Outer Retinal Layers to Visual Acuity Recovery (2017) (23)
- Transgenic mice overexpressing growth hormone (GH) have reduced or increased cardiac apoptosis through activation of multiple GH-dependent or -independent cell death pathways. (2008) (23)
- Management of Graves’ hyperthyroidism and orbitopathy in time of COVID-19 pandemic (2020) (23)
- GH secretion is impaired in patients with primary hyperparathyroidism. (2002) (22)
- Management of Subclinical Hypothyroidism in Pregnancy: A Comment from the Italian Society of Endocrinology and the Italian Thyroid Association to the 2017 American Thyroid Association Guidelines-"The Italian Way". (2018) (22)
- Surgery of lymph nodes in papillary thyroid cancer (2006) (22)
- Plasma total and acylated Ghrelin concentrations in patients with clinical and subclinical thyroid dysfunction (2009) (22)
- The presence of anti-thyroglobulin (TgAb) and/or anti-thyroperoxidase antibodies (TPOAb) does not exclude the diagnosis of type 2 amiodarone-induced thyrotoxicosis (2016) (21)
- Soluble interleukin‐1 receptor antagonist concentration in patients with Graves' ophthalmopathy is neither related to cigarette smoking nor predictive of subsequent response to glucocorticoids (2000) (21)
- [Amiodarone and the thyroid]. (1995) (21)
- Somatostatin analogs for Graves' ophthalmopathy: do they bounce off like a rubber bullet? (2004) (21)
- Glucocorticoids and outcome of radioactive iodine therapy for Graves' hyperthyroidism. (2005) (21)
- Graves’ hyperthyroidism and ophthalmopathy associated with pemphigus vulgaris: Onset of thyroid autoimmune disease during chronic low-dose glucocorticoid therapy (1997) (21)
- The age of patients with thyrotoxicosis factitia in Italy from 1973 to 1996 (1999) (20)
- Changes in the expression of the peroxisome proliferator-activated receptor gamma gene in the colonic polyps and colonic mucosa of acromegalic patients. (2003) (20)
- Radiation and Graves' ophthalmopathy (1995) (19)
- Relation between Graves’ orbitopathy and radioiodine therapy for hyperthyroidism: facts and unsolved questions * (2008) (19)
- Thyroid vascularity is increased in patients with active acromegaly (2002) (19)
- Dissociation of responsiveness to thyrotropin-releasing hormone and thyroid suppressibility following antithyroid drug therapy of hyperthyroidism. (1976) (18)
- Teprotumumab: a new avenue for the management of moderate-to-severe and active Graves’ orbitopathy? (2017) (18)
- Thyroid hormone and thyrotropin regulate intracellular free calcium concentrations in human polymorphonuclear leukocytes: in vivo and in vitro studies. (2006) (18)
- Cigarette smoking: number one enemy for Graves ophthalmopathy. (2016) (18)
- Smoking and Graves’ disease (2002) (18)
- Effects of amiodarone, thyroid hormones and CYP2C9 and VKORC1 polymorphisms on warfarin metabolism: a review of the literature. (2013) (18)
- Proposal for Standardization of Primary and Secondary Outcomes in Patients with Active, Moderate-to-Severe Graves’ Orbitopathy (2020) (17)
- Will biological agents supplant systemic glucocorticoids as the first-line treatment for thyroid-associated ophthalmopathy? (2019) (17)
- Change in newly diagnosed Graves’ disease phenotype between the twentieth and the twenty-first centuries: meta-analysis and meta-regression (2020) (17)
- An update on the pharmacological management of hyperthyroidism due to Graves’ disease (2005) (17)
- Cardiometabolic healthy and unhealthy obesity: does vitamin D play a role? (2017) (17)
- Effect of the antileukemic agent L-asparaginase on thyroxine-binding globulin and albumin synthesis in cultured human hepatoma (HEP G2) cells. (1986) (17)
- Levothyroxine suppressive therapy: Harmful and useless or harmless and useful? (1994) (16)
- Thyroid color flow Doppler sonography: an adjunctive tool for differentiating patients with inappropriate thyrotropin (TSH) secretion due to TSH-secreting pituitary adenoma or resistance to thyroid hormone. (2006) (16)
- Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study (2020) (16)
- Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study (2020) (16)
- SIGNIFICANCE OF THYROID AUTOANTIBODIES IN AUTOIMMUNE THYROID DISEASES (1985) (16)
- Current medical management of Graves ophthalmopathy. (2002) (16)
- The dilemma of non-thyroidal illness syndrome: to treat or not to treat? (2003) (16)
- The lack of nocturnal serum thyrotropin surge in patients with nontoxic nodular goiter may predict the subsequent occurrence of hyperthyroidism. (1991) (16)
- Immunological Drivers in Graves' Disease: NK Cells as a Master Switcher (2020) (16)
- Masked hypertension in newly diagnosed hypothyroidism: a pilot study (2016) (16)
- Orbital cobalt radiotherapy and systemic or retrobulbar corticosteroids for Graves' ophthalmopathy. (1987) (16)
- Interleukin-6 levels are not increased in women with postpartum thyroid dysfunction. (1998) (16)
- Nodule size and fine-needle aspiration biopsy: diagnostic challenges for thyroid malignancy. (2011) (16)
- Circulating antibodies to DNA-related antigens in patients with autoimmune thyroid disorders. (1992) (15)
- The effect of altered thyroid function on serum fructosamine concentrations. (1988) (15)
- Amiodarone and the thyroid. (2015) (14)
- Effects of thyroxine excess on peripheral organs. (1994) (14)
- Graves' ophthalmopathy: reality and perspectives (2000) (14)
- Clinical usefulness and limitations of serum thyrotropin measurement by 'ultrasensitive' methods. Comparisons of five kits. (1987) (14)
- Novel approaches to the management of graves' ophthalmopathy. (2002) (14)
- A teleconsultation network improves the efficacy of anti-VEGF therapy in retinal diseases (2013) (14)
- Commentary: rituximab, adalimumab, etanercept, tocilizumab--are biologics the future for Graves' orbitopathy? (2014) (14)
- Changes in the expression of suppressor of cytokine signalling (SOCS) 2 in the colonic mucosa of acromegalic patients are associated with hyperplastic polyps (2009) (13)
- Treatment of Graves’ hyperthyroidism with thionamides: a position paper on indications and safety in pregnancy (2019) (13)
- Physical performance in newly diagnosed hypothyroidism: a pilot study (2017) (13)
- Pendrin does not increase sulfate uptake in mammalian COS-7 cells (2000) (13)
- Features and outcome of differentiated thyroid carcinoma associated with Graves’ disease: results of a large, retrospective, multicenter study (2020) (13)
- Graves’-like orbitopathy: do not forget IgG4-related disease (2014) (13)
- Graves’ hyperthyroidism of recent onset and Graves’ orbitopathy: To ablate or not to ablate the thyroid? (2008) (13)
- Teprotumumab for Graves’ orbitopathy and ototoxicity: moving problems from eyes to ears? (2022) (12)
- Management of Graves’ hyperthyroidism: present and future (2022) (12)
- Measurement of thyroid cell surface antibodies by radioassay using human cultured thyroid cells (1981) (12)
- A new ophthalmopathy index for quantitation of eye changes of Graves' disease (1989) (12)
- [Current indications for thyroidectomy]. (2007) (12)
- Orbital radiotherapy in the treatment of endocrine ophthalmopathy: when and why? (1993) (12)
- Radioimmunoassay for human thyroxine-binding prealbumin. (1986) (11)
- Changes in Autonomic Modulation to the Heart and Intracellular Catecholamines (2006) (11)
- Improvement of growth hormone deficiency in patients with primary hyperparathyroidism after parathyroidectomy: results of a prospective study. (2004) (11)
- Purification and partial characterization of a novel thyroxine-binding protein (27K protein) from human plasma. (1986) (11)
- Absence of serum thyroid hormone autoantibodies in patients chronically treated with amiodarone (1988) (11)
- Serum free thyroid hormones in subclinical hypothyroidism (1986) (11)
- Adjuvant effect of lithium on radioiodine treatment of hyperthyroidism. (2002) (11)
- Free thyroxine and free triiodothyronine measurement in dried blood spots on filter paper by column adsorption chromatography followed by radioimmunoassay. (1988) (10)
- Selenium in the Treatment of Thyroid Diseases (2017) (10)
- Graves’ Ophthalmopathy (2019) (10)
- Potassium perchlorate only temporarily restores euthyroidism in patients with amiodarone-induced hypothyroidism who continue amiodarone therapy (2008) (10)
- Environment and thyroid autoimmunity (2007) (9)
- Orbital decompression for severe Graves' ophthalmopathy. Results of a three-wall operative technique. (1989) (9)
- Graves’ Disease: Complications (2014) (9)
- Pain Perception, Blood Pressure Levels, and Peripheral Benzodiazepine Receptors in Patients Followed for Differentiated Thyroid Carcinoma: A Longitudinal Study in Hypothyroidism and During Hormone Treatment (2007) (9)
- Gastrin (G) cells are the cellular site of the gastric thyrotropin-releasing hormone in human fetuses and newborns. A chromatographic, radioimmunological, and immunocytochemical study. (1992) (9)
- Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves’ Disease Hyperthyroidism During Methimazole Treatment (2022) (9)
- Color Flow Doppler Sonography of the Thyroid (2000) (9)
- Orbital radiation therapy for Graves' ophthalmopathy. (2003) (9)
- Studies on thyroxine-binding globulin (1993) (9)
- Radioimmunoassay of Thyroid Hormones (1987) (9)
- Medullary thyroid carcinoma: surgical treatment advances (2007) (9)
- Non-autoimmune hyperthyroidism associated with isolated bilateral ocular lymphoma mimicking Graves’ disease with ophthalmopathy: A cause of misdiagnosis (1995) (9)
- The differentiation-inducing agent sodium butyrate produces divergent effects on albumin and thyroxine-binding globulin synthesis by human hepatoblastoma-derived (Hep G2) cells (1990) (8)
- Changes in radioimmunoassayable prealbumin (TBPA) serum levels from birth to adulthood. (1986) (8)
- Thyroid autoimmunity and endemic goiter. (1986) (8)
- Antithyroid drug treatment prior to radioiodine therapy for Graves’ disease: Yes or no? (2003) (8)
- Ectopic submandibular thyroid tissue with a coexisting normally located multinodular goitre: case report and review of the literature (2009) (8)
- Oral steroid prophylaxis for Graves’ orbitopathy after radioactive iodine treatment for Graves’ disease is not only effective, but also safe (2020) (8)
- Analysis of voice in patients with untreated active acromegaly (2010) (8)
- Radioiodine and thyroid-associated ophthalmopathy (1996) (7)
- Growth hormone secretion in primary and secondary hyperparathyroidism (2005) (7)
- Novel treatment modalities for Graves' orbitopathy. (2010) (7)
- Reference values in endocrinology (2001) (7)
- Amiodarone‐induced thyrotoxicosis, an overview of UK management (2012) (7)
- Thyroid Hormone-Binding Proteins (2004) (7)
- [The neonatal respiratory insufficiency syndrome: the role of the chest radiogram]. (1997) (7)
- Uptake of amiodarone by thyroidal and non-thyroidal cell lines (2006) (7)
- Duration of exposure to thyrotoxicosis increases mortality of compromised AIT patients: the role of early thyroidectomy. (2020) (7)
- Immunotherapy for Graves’ orbitopathy: Easy enthusiasm, but let’s keep trying (2006) (7)
- Effect of high-dose intravenous glucocorticoid therapy on serum thyroid hormone concentrations in type 2 amiodarone-induced thyrotoxicosis: an exploratory study (2020) (6)
- Interference of thyroglobulin in TSAb detection by radio-receptor assay (1979) (6)
- Current concepts regarding Graves’ orbitopathy (2022) (6)
- Biosynthesis of a novel thyroxine-binding protein (27K protein) in human hepatoma (Hep G2) cells. (1986) (6)
- TSH-displacing activity versus TSH-binding inhibiting activity of immunoglobulins from patients with Graves’ disease (1983) (6)
- Currently available somatostatin analogs are not good for Graves’ orbitopathy (2006) (6)
- Is thyroxine during lithium therapy necessary? (1999) (6)
- Percutaneous ethanol injection: what is its role in the management of nodular lesions of endocrine glands? (1995) (6)
- Can combination of glucocorticoids with other immunosoppressive drugs reduce the cumulative dose of glucocorticoids for moderate-to-severe and active Graves’ orbitopathy? (2019) (6)
- Iodine contamination in subjects admitted to a general hospital (1992) (6)
- Radioiodine treatment of Grave's hyperthyroidis, and progression of ophthalmopathy: protective effect of systemic corticosteroids (1989) (6)
- Recent progress in Graves' ophthalmopathy (1996) (6)
- Interaction of the thyrotropin receptor on rat FRTL-5 thyroid cells with thyrotropin and a thyrotropin-stimulating autoantibody from Graves' patients. (1987) (5)
- Primary hyperparathyroidism is associated with an impaired secretion of growth hormone but not of the other anterior pituitary hormones (2002) (5)
- Treatment of moderate-to-severe and active Graves’ orbitopathy: a step forward from the OPTIC study (2020) (5)
- Cardiac expression of adenine nucleotide translocase-1 in transgenic mice overexpressing bovine GH. (2007) (5)
- Free thyroxine values in dried blood spots on filter paper in newborns are related to both gestational age and birth body weight (1988) (5)
- Serum thyroid hormones and thyroid hormone binding proteins in patients with completed stroke. (1986) (5)
- Identification of two different phenotypes of patients with amiodarone-induced thyrotoxicosis and positive thyrotropin receptor antibody tests. (2021) (5)
- Methimazole treatment and acute pancreatitis: both caution and reassurance are needed. (2020) (5)
- Happy Birthday, Journal of Endocrinological Investigation! (2017) (5)
- Colonic polyps of acromegalic patients are not associated with mutations of the peroxisome proliferator activated receptor γ gene (2003) (5)
- Further studies on the role of glycosylation in thyroxine-binding globulin secretion by human hepatoma (HEP G2) cells. (1987) (5)
- Acoustic reflex characteristics in hypo- and hyperthyroid patients. (1984) (5)
- Psychological complications in patients with acromegaly: relationships with sex, arthropathy, and quality of life (2022) (5)
- Reduced colonic apoptosis in mice overexpressing bovine growth hormone occurs through changes in several kinase pathways. (2009) (4)
- Graves’ ophthalmopathy: Search for shared autoantigen(s) continues (2005) (4)
- Shortening hospital stay for thyroid surgery (2008) (4)
- Ontogeny of nyctohemeral variations of thyrotropin-releasing hormone in rat hypothalamus. (1986) (4)
- Glucocorticoid administration for Graves’ hyperthyroidism treated by radioiodine. A questionnaire survey among members of the European Thyroid Association (2010) (4)
- Time interval in diagnosis and treatment of papillary thyroid cancer: a descriptive, retrospective study. (2009) (4)
- Treatment with thionamides before radioiodine therapy for hyperthyroidism: yes or no? (2005) (4)
- Treating Graves’ orbitopathy: where are we? (2012) (4)
- A thyroid nodule in a young Sicilian princess in 1900 (2019) (4)
- Steroid prophylaxis after radioiodine treatment for Graves' hyperthyroidism: selective or universal? (2014) (4)
- Thyroid function tests and diagnostic protocols for investigation of thyroid dysfunction. (1991) (4)
- Use of solubilized radioiodinated thyroid plasma membranes for purification of TSH‐receptor by affinity chromatography (1978) (3)
- Serum prostate-specific antigen concentration is increased in acromegalic women (2004) (3)
- Circulating levels of anticonvulsant metabolites of progesterone in women with partial epilepsy in the intercritical phase (1996) (3)
- [Orbital decompression in Grave's disease: comparison of techniques]. (1999) (3)
- Iodine and thyroid dysfunction in uremia. (1990) (3)
- Graves’ orbitopathy represented as feature of a state of mind (2020) (3)
- Macular Edema and Silicone Oil Tamponade (2014) (3)
- A potential role of human RNASET2 overexpression in the pathogenesis of Graves’ disease (2022) (3)
- A mathematical model of thyroid mass reduction after radioiodine therapy of Graves’ disease (2001) (3)
- Effects of the antileukemic drug L-asparaginase on sex hormone-binding globulin: studies in vivo and in vitro (1989) (3)
- Abnormal expression of PPAR gamma isoforms in the subcutaneous adipose tissue of patients with Cushing's disease (2006) (3)
- Serum TSH measurements by a sensitive enzyme immunoassay discriminate euthyroid from hyperthyroid subjects and avoid the need for TRH test during suppressive therapy with L-thyroxine. (1987) (3)
- Adequacy of TSH suppression by L-thyroxine administration in thyroid cancer patients after total thyroidectomy. (1986) (3)
- Management of Graves orbitopathy (2017) (2)
- The dilemma of non-thyroidal illness: to treat or not to treat? (2003) (2)
- Can a patient-tailored treatment approach for Graves' disease reduce mortality? (2019) (2)
- Acromegaly in digital art (2019) (2)
- The artist’s wife with a simple nontoxic goiter (2020) (2)
- Human Hepatoma (Hep G2) Cells Secrete a Novel T4-Binding Protein (27 K Protein) (1986) (2)
- When primary hyperparathyroidism comes as good news (2020) (2)
- Diagnosis of thyroid dysfunction: present and future. (1994) (2)
- Cigarette Smoking and Thyroid Eye Disease (2002) (2)
- Current Medical Management of Thyroid Orbitopathy (2005) (2)
- Statins for Graves' orbitopathy: a new tool for prevention and treatment? (2021) (2)
- The Virgin Mary with a small goiter breastfeeding the Child (2020) (2)
- The reduction of bone mineral density in postmenopausal women with primary hyperparathyroidism is higher in the presence of concomitant GH secretion impairment. (2006) (2)
- Eyelid myiasis caused by Cordylobia anthropophaga (2015) (2)
- Protocols of Non-Surgical Therapies (2017) (2)
- A Marker of Thyroid-Destructive Processes?* (1994) (2)
- Childhood Graves' Orbitopathy (2017) (1)
- Maria Carolina of Austria, Queen of Naples and Sicily: a possible case of Graves’ orbitopathy (2017) (1)
- Iodine supplementation in women of reproductive age: a survey of clinical practice among Italian gynecologists and midwives (2019) (1)
- Identification, treatment and management of cardiovascular risks in patients with acromegaly (2008) (1)
- Sight-Threatening Graves’ Orbitopathy (2015) (1)
- Comics’ representation of Graves’ orbitopathy, by Emil Ferris (2021) (1)
- Serum thyroglobulin concentration may be a clue to the mechanism of amiodarone-induced thyrotoxicosis (1988) (1)
- The clinical enigma of the “Flea catcher” by Georges de La Tour: a pregnant sinner with pre-eclampsia or a hypothyroid girl? (2019) (1)
- The multinodular goiter of the virtuous Roman matron Lucretia by Artemisia Gentileschi (2019) (1)
- Thyroxine uptake by human hepatoma cells from serum of patients submitted to long-term thyroxine suppressive therapy (1988) (1)
- Reply to: Comment on EUGOGO CLINICAL PRACTICE GUIDELINES. (2021) (1)
- Serum Thyroid Hormone-Binding Proteins (2019) (1)
- Treatment of Graves’ Ophthalmopathy by Retrobulbar Corticosteroids Associated With Orbital Cobalt Radiotherapy (1987) (1)
- Perspectives in pharmacological management of Graves’ hyperthyroidism and orbitopathy (2008) (1)
- The role of somatostatin analogs in the management of Graves' ophthalmopathy. (2003) (1)
- Graves’ Orbitopathy: do not give it for granted (2018) (1)
- Hyperthyroidism Due to Graves‗ Disease – Is There an Optimal Pharmacological Treatment Regimen? (2008) (1)
- Selenium and pentoxifylline in patients with mild Graves' orbitopathy: Results of a randomized placebo-controlled double-blind clinical trial (2010) (1)
- Acknowledgement to Reviewers (2012) (0)
- Liver enzymes alterations during high dose intravenous glucocorticoid pulse therapy for graves ophthalmopathy: frequency and putative risk factors (2006) (0)
- JCEM ARCHIVEApproach to the Patient with Amiodarone-Induced Thyrotoxicosis (2011) (0)
- Thyroid Hormone Treatment for Differentiated Thyroid Carcinoma: What Drug, How Long, What Dose? (2009) (0)
- Graves’ orbitopathy: lessons from Representational Art (2021) (0)
- 2021 Asia-Pacific Graves’ Disease Consortium Survey of Clinical Practice Patterns in the Management of Graves’ Disease (2022) (0)
- What is the Role of Medical Therapy in the Management of Graves’ Orbitopathy? (2014) (0)
- Table 3, NO SPECS classification of eye changes of Graves’ disease (2014) (0)
- Table 8, Management of moderate-to-severe Graves’ orbitopathy (2014) (0)
- Recent advances on thyroxine-binding globulin. (1988) (0)
- Faculty Opinions recommendation of Teprotumumab for the treatment of active thyroid eye disease. (2020) (0)
- In memoriam Professor Aldo Pinchera (1934–2012) (2012) (0)
- SIE, SIAMS, SIEDP, SIO, AIT, AME Informano (2011) (0)
- Progress in immunosuppressive treatment of GO (selenium, steroid dosage, rituximab) (2012) (0)
- Serum prostate-specific antigen is increased in acromegalic women (2004) (0)
- Treatment of Hyperthyroidism in Patients with Graves’ Orbitopathy (2015) (0)
- Response to comment by Smith on the 2021 EUGOGO guidelines (2021) (0)
- VATHT (Venous and Arterial Thrombosis History and Thyroid) study (2006) (0)
- Interleukin 6 effects on the pituitary \ p = n-\ thyroid axis in the rat (2008) (0)
- The Challenge of Orbital Decompression in a Patient with Multiple Autoimmune Diseases and Graves’ Orbitopathy: A Case Report and Review of Literature (2010) (0)
- Contents Vol. 2, 2014 (2013) (0)
- Pituitary disorders as wonders and curiosity in XVI Century (2019) (0)
- Smoking and the Thyroid (2004) (0)
- The management of Graves' ophthalmopathy and dermopathy (2011) (0)
- A young lady with goiter by Mario Sironi (1885–1961) (2020) (0)
- Table 2, Risk factors for the occurrence/progression of Graves’ orbitopathy and preventive measures (2014) (0)
- Professor Aldo Pinchera (1934–2012) (2012) (0)
- [Thyroid uptake of I131 in iodine-induced thyroid pathology caused by amiodarone]. (1988) (0)
- General Management Plan for Graves' Orbitopathy (2017) (0)
- Grave's ophthalmopathy (GO), are the extrathyroidal manifestations of Grave's disease. Foreword. (2010) (0)
- Faculty Opinions recommendation of Comparison of mortality in hyperthyroidism during periods of treatment with thionamides and after radioiodine. (2013) (0)
- 43rd SEMDSA and 13th NOFSA Congresses and 11th DESSA Workshop (2008) (0)
- Hyperthyroidism and thyrotoxicosis (2001) (0)
- A four day long meeting designed for pathologists, endocrinologists, neurosurgeons interested in pituitary pathology. The course will provide a comprehensive coverage of pathogenetic and histopathological features of pituitary adenomas and an overview on lesions of the parasellar region. Meeting Org (2008) (0)
- Cushing syndrome at the court of the infant of Spain in the eighteenth century? (2020) (0)
- Perspective Current Medical Management of Graves Ophthalmopathy (2002) (0)
- [Treatment of Basedow's ophthalmopathy: a comparative evaluation of systemic or retrobulbar administration of corticosteroids associated with orbital radiotherapy]. (1988) (0)
- Amiodarone and the thyroid Amiodaron i (2015) (0)
- LETTERS TO THE EDITORS (1986) (0)
- Thyroid eye disease and radioiodine therapy for Graves' hyperthyroidism (2003) (0)
- Iopanoic acid allows a rapid control of Type I and type II amiodarone-induced thyrotoxicosis prior to thyroidectomy (2002) (0)
- Table 7, Management of mild Graves’ orbitopathy (2014) (0)
- Pathogenetic role of enteroviruses in type 1 diabetes (2012) (0)
- Role of teprotumumab in the treatment of active moderate-to-severe Graves' orbitopathy. (2022) (0)
- Real-life data on the impact of medical therapy for amiodarone-induced thyrotoxicosis on CV events and hospitalizations. (2022) (0)
- Antithyroid Drugs for Thyrotoxicosis (2021) (0)
- Faculty Opinions recommendation of A cautious iodization programme bringing iodine intake to a low recommended level is associated with an increase in the prevalence of thyroid autoantibodies in the population. (2011) (0)
- Ontogeny of Pancreatic TRH Occurs Independently of Brain Development (1989) (0)
- Immunomodulatory role of vitamin D and selenium supplementation in newly diagnosed Graves’ disease patients during methimazole treatment (2023) (0)
- Treatment of Graves’ Disease (2018) (0)
- [CT of the orbit in Graves' ophthalmopathy]. (1990) (0)
- 151 Radioimmunoassayble Prealbumin in newborns, infants, children and adolescents (1985) (0)
- Total thyroidectomy for amiodarone-induced thyrotoxicosis: Identification of the surgical candidates and preparation to surgery (2020) (0)
- Treatment of hyperthyroidism: block and replace versus titration (2008) (0)
- Are overt hyperthyroidism and subclinical hypotyroidism associated with DVT? A pilot study (2006) (0)
- ceptor for the thiazolidinedione class of antidiabetic drugs and may function as a tumor suppressor gene (4, 5): a fusion of PPAR to PAX8 was reported in thyroid papillary carcinomas (6); PPAR activation by troglitazone induces differentiation of liposar- (0)
- Table 6, Clinical Activity Score (CAS). (2014) (0)
- Reply to Letter to the Editor by Dr. Terry J. Smith regarding teprotumumab and ototoxicity (2022) (0)
- Effects of Chronic Amiodarone Administration on Humoral Thyroid Autoimmunity (1987) (0)
- Table 5, Assessment of severity of Graves’ orbitopathy (2014) (0)
- An analysis on delays in diagnosis of papillary thyroid cancer (2007) (0)
- Breeding density and Muscovy duck behaviour (1990) (0)
- Contents Vol. 1, 2012 (2013) (0)
- List of referees (2003) (0)
- Favourable outcome of Graves ophthalmopathy (GO) after glucocorticoids (GC) in patients treated with total thyroid ablation (TTA): results of a randomized clinical trial (2006) (0)
- JAMA Peer Reviewers for 2003 (2017) (0)
- Humoral autoimmunity in endocrine ophthalmology (1989) (0)
- Pre-operative evaluation of obese patients admitted for bariatric surgery: observations suggesting the introduction of a detailed screening for thyroid diseases (2018) (0)
- Different prevalence of type 1 and type 2 amiodarone-induced thyrotoxicosis over a 30-year period (2007) (0)
- Faculty Opinions recommendation of Radioiodine-Associated Exacerbation of Graves' Orbitopathy in the Japanese Population: Randomized Prospective Study. (2015) (0)
- What you choose makes the difference: the first medical therapy for amiodarone-induced thyrotoxicosis has significant implications on cardiovascular events and hospitalizations (2022) (0)
- Meeting abstracts from the 64th British Thyroid Association Annual Meeting (2017) (0)
- Simultaneous occurrence of multicentric medullary and papillary thyroid cancer: a case report (2007) (0)
- Metabolic profile reversal after bariatric surgery (2017) (0)
- Subject Index, Vol. 26, 1987 (1987) (0)
- Role of teprotumumab in the treatment of active moderate-to-severe Graves’ orbitopathy (2022) (0)
- Demographic and baseline characteristics of an obese population admitted for bariatric surgery in a secondary care centre (2017) (0)
- Recent Findings on Thyroid Function in Depression (1993) (0)
- Jacob Robbins (2009) (0)
- Subject Index, Vol. 26, 1987 (1987) (0)
- Subject Index Vol. 1, 2012 (2013) (0)
- 2. Patient with Amiodarone-Induced Thyrotoxicosis (2012) (0)
- Radioiodine therapy and Graves' ophthalmopathy. (2002) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Luigi Bartalena?
Luigi Bartalena is affiliated with the following schools:
